Absci (ABSI) Invested Capital (2020 - 2026)
Absci (ABSI) posted Invested Capital of $12.8 million for Q3 2025, little changed sequentially from $12.8 million in Q2 2025.
Analysis
Absci (ABSI) Invested Capital (2020 - 2026) Analysis & Trends
Absci has reported Invested Capital for 6 years, with the latest figure at $12.8 million in Q3 2025.
- Quarterly Invested Capital changed N/A year-over-year to $12.8 million in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $25.5 million (up 98.78% YoY) and the FY2024 annual result came in at $78000.0, down 89.12% from the prior year.
- Invested Capital held at $12.8 million in Q3 2025 per ABSI's latest filing, from $12.8 million in the prior quarter.
- Over five years, Invested Capital peaked at $12.8 million in Q1 2025 and troughed at $78000.0 in Q4 2024.
- A 5-year average of $6.7 million and a median of $6.0 million in 2021 frame the typical range for Invested Capital.
- The sharpest annual moves came in 2021 and 2024: Invested Capital soared 851.9% in 2021, then slumped 89.12% in 2024.
- Over 5 years, Invested Capital stood at $6.0 million in 2021, then tumbled by 49.37% to $3.0 million in 2022, then plunged by 76.46% to $717000.0 in 2023, then plunged by 89.12% to $78000.0 in 2024, then soared by 16246.15% to $12.8 million in 2025.
- According to Business Quant data, Invested Capital over the past three periods registered $12.8 million, $12.8 million, and $12.8 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Absci | 1.39 Bn | 1.19 Bn | - | 246.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 246.28 Mn |
| Mar 31, 2026 | 172.38 Mn |
| Dec 31, 2025 | 190.32 Mn |
| Sep 30, 2025 | 224.46 Mn |
| Jun 30, 2025 | 188.27 Mn |
| Mar 31, 2025 | 214.77 Mn |
| Dec 31, 2024 | 195.87 Mn |
| Sep 30, 2024 | 206.76 Mn |
| Jun 30, 2024 | 227.73 Mn |
| Mar 31, 2024 | 247.15 Mn |
| Dec 31, 2023 | 196.84 Mn |
| Sep 30, 2023 | 205.18 Mn |
| Jun 30, 2023 | 224.92 Mn |
| Mar 31, 2023 | 264.23 Mn |
| Dec 31, 2022 | 285.34 Mn |
| Sep 30, 2022 | 301.81 Mn |
| Jun 30, 2022 | 325.45 Mn |
| Mar 31, 2022 | 343.43 Mn |
| Dec 31, 2021 | 369.63 Mn |
| Sep 30, 2021 | 392.13 Mn |